Method and system for preventing sore throat in humans
AssigneeSeed Health, Inc.
InventorJoseph E. Kovarik
Life of this patent
Estimating the term…
Abstract
A method and system to prevent sore throat infections in humans includes the administration of an active ingredient to a site on the mucus membranes of the throat of a human that inhibits adherence and promotes desorption of S. pyogenes to soft tissue surfaces, such as the pharyngeal and oral mucosa of a human. A mucoadhesive strip having a surface topography that resists bioadhesion of undesired bacteria that are typically present in a human's mouth is preferably employed and that has one or more encapsulated agents selected from the group consisting of an antibiotic; lactic acid bacteria; S. pyogenes modified by a CRISPR-Cas system to reduce one or more virulence factors; and a breath mint solution.
Claims11
A system for reducing the likelihood of Streptococcus pyogenes infections in a human being, comprising, a solid strip having a first and second side, said first side having a bioadhesive that is adapted to bind to a mucosal membrane for at least 1 hour while inside a person's mouth, and wherein said strip includes one of an analgesic, and a lactic acid bacteria that coaggregates with Streptococcus pyogenes, said lactic acid bacteria selected from the group consisting of Lactobacillus lactis, Lactobacillus helveticus, Lactobacillus jensenii, Lactobacillus acidophilus, Lactobacillus bulgaricus, Lactobacillus amylovorus, Lactobacillus delbrueckii, Lactobacillus casei, Lactobacillus crispatus, Lactobacillus gasseri, Lactobacillus johnsonii, Lactobacillus paracasei, Lactobacillus pentosus, Lactobacillus rhamnosus, Lactobacillus curvatus, Lactobacillus plantarum, Lactobacillus brevis, Lactobacillus buchneri, Lactobacillus fructivorans, Lactobacillus hilgardii, Lactobacillus fermentum, Lactobacillus viridescens, Bifidobacterium bifidum, and Lactobacillus ingluviei, wherein said strip has an analgesic encapsulated inside a frangible encapsulation structure that is broken by a person pressing against said strip with the person's tongue and wherein said encapsulation structure is devoid of liposomes.
A system for reducing the likelihood of Streptococcus pyogenes infections in a human being, comprising, a solid strip having a first and second side, said first side having a bioadhesive that is adapted to bind to a mucosal membrane for at least 1 hour while inside a person's mouth, and wherein said strip includes a lactic acid bacteria that coaggregates with Streptococcus pyogenes, wherein said lactic acid bacteria comprises Lactobacillus crispatus, and wherein said lactic acid bacteria is encapsulated inside a frangible encapsulation structure that is broken by a person pressing against said strip with the person's tongue and wherein said encapsulation structure is devoid of liposomes.
Dependencies are inferred from the claim text.